The functional indications of Opicapone
Ongentys (Opicapone), as a third-generation COMT inhibitor, is mainly used as an adjuvant therapy for Parkinson's disease patients, improving motor fluctuation symptoms by prolonging the action time of levodopa.
1 Core therapeutic function
(1) Indication positioning: As an adjuvant medication for levodopa/carbidopa, specifically targeting the "off phase" symptoms that occur during the treatment of Parkinson's disease.
(2) Mechanism of action: By reversibly inhibiting peripheral COMT enzyme, the metabolism of levodopa is reduced by 60%, significantly prolonging its plasma half-life.
2 Clinical efficacy manifestations
(1) Symptom improvement: Daily single dose administration can prolong the "on period" time by 1.5-2 hours and reduce the frequency of "off period" attacks by 30-40%.
(2) Advantages of medication: Compared to traditional COMT inhibitors, it has a more potent and long-lasting peripheral COMT inhibitory effect.
3 Special therapeutic values
(1) Convenience of administration: The 50mg bedtime single dose regimen significantly improves medication adherence.
(2) Less drug interactions: Not metabolized by CYP450 enzymes, reducing the risk of interactions with other drugs.
Disclaimer：《The functional indications of Opicapone》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！